doi: 10.3389/fimmu.2020.01965 Summary Keywords systemic lupus erythematosus, chimeric antigen receptor T-cell, CD19, BCMA, therapeutic strategy, clinical implications Citation Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y, Zhang Y, Liu R, Wang H, Zhou J and He X (2024) CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives
Injectable protocols deliver the peptide systemically, distributing it through circulation to reach tissues throughout the research model
2021 study (PMID: 33996787) demonstrated selectivity in human chondrocyte cultures, but long-term effects on stem cell niches have not been systematically studied
The quantities differ too
A few studies have investigated the role of glutathione-S-transferase and esterases in ivermectin resistance in ticks and scabies mites
NAIDU, N.V., REDDY, K.S., JANARDHAN, A., & MURTHY, M.K